Human PRKD3 adenoviral particles

The PRKD3 gene, also known as protein kinase D3, encodes a serine/threonine kinase that belongs to the protein kinase D (PKD) family. The gene plays a key role in processes such as cell proliferation, differentiation, apoptosis, and regulation of immune responses. PRKD3 is activated by diacylglycerol (DAG) and phospholipase C-coupled receptors and affects downstream signaling pathways, including NF-κB and MAPK. Dysregulation of PRKD3 has been implicated in a variety of diseases, especially cancer, where it often leads to tumor progression and metastasis. Given its critical role in cell signaling, PRKD3 is a promising target for therapeutic intervention and functional studies. Human PRKD3 adenoviral particles are replication-defective viral vectors designed to efficiently deliver the PRKD3 gene to mammalian cells. These particles exploit the natural tropism of adenoviruses to infect a broad range of cell types, including dividing and non-dividing cells, making them ideal for in vitro and in vivo studies. This adenoviral system ensures stable and transient expression of PRKD3, allowing researchers to explore its functional role in signaling pathways, disease models, or therapeutic applications. These particles are purified and titrated to ensure consistent performance. Applications range from gain-of-function experiments to preclinical studies of gene therapy.